Veneziani, Ana C.
Gonzalez-Ochoa, Eduardo https://orcid.org/0000-0002-1056-5967
Alqaisi, Husam
Madariaga, Ainhoa https://orcid.org/0000-0001-7166-9762
Bhat, Gita
Rouzbahman, Marjan
Sneha, Suku
Oza, Amit M. https://orcid.org/0000-0002-9510-8641
Article History
Accepted: 4 September 2023
First Online: 2 October 2023
Competing interests
: A.M. has received honoraria from AstraZeneca, Clovis, GSK and PharmaMar. A.M.O. is a principal investigator and participates in steering committees of trials sponsored by AstraZeneca, Clovis (without compensation) and GSK, and is the CEO of Ozmosis Research (without compensation). The other authors declare no competing interests.